Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when ZLAB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsZai Lab President and COO Josh Smiley departs immediately, CEO assumes responsibilities
Filed May 21, 2026 · Period ending May 18, 2026 · ~1 min read
Key Changes
-
high
President and Chief Operating Officer Josh Smiley ceased serving effective May 18, 2026, with final employment day May 22. The departure was immediate and the position is not being refilled.
Item 5.02 verify on EDGAR → -
medium
CEO Samantha Du and existing management team absorbed all President and COO responsibilities rather than hiring a replacement, concentrating operational control at the CEO level.
Item 5.02 verify on EDGAR → -
low
Smiley will receive severance per his employment agreement subject to signing a standard release, suggesting a negotiated rather than for-cause departure.
Item 5.02 verify on EDGAR →
Summary
Zai Lab announced the immediate departure of President and COO Josh Smiley, effective May 18, 2026. The company is not replacing the position; instead, CEO Samantha Du and other management team members have assumed his operational responsibilities. This represents a significant consolidation of leadership at a biotech company commercializing oncology therapies in China.
For retail investors, the sudden departure of a C-suite operating executive raises questions about strategic direction and internal dynamics, though the negotiated severance suggests an orderly transition. The decision not to refill the role may signal cost discipline or a shift in organizational structure as the company matures. Watch for any operational disruptions or changes in commercial execution in upcoming quarterly results, particularly around the company's marketed products and pipeline progress.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On May 18, 2026, the Board of Directors of Zai Lab Limited (the “Company”) determined that Mr. Josh Smiley will cease serving as President and Chief Operating Officer of the Company, effective as of May 18, 2026, and his last day of employment with the Company will be May 22, 2026.
Josh Smiley ceased serving as President and Chief Operating Officer effective May 18, 2026, with his employment ending May 22, 2026. This is an immediate departure of a senior executive overseeing operations. The responsibilities have been redistributed to CEO Samantha Du and other management team members.
Added in current filing · verify on EDGAR →
The responsibilities previously associated with such positions have been assumed by Samantha Du, the Company’s Board Chair, Founder and Chief Executive Officer, and other members of the Company’s management team.
The President and COO duties are now handled by CEO Samantha Du and other management team members rather than being filled by a new hire. This consolidation may indicate organizational restructuring or cost management, though it also concentrates responsibilities at the CEO level.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Mr. Smiley will receive severance pursuant to his existing employment agreement, subject to his execution of a customary release.
The departing executive will receive severance payments as specified in his employment agreement, contingent on signing a standard release. This suggests the departure was negotiated rather than for-cause termination, though the specific severance amount is not disclosed.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 27, 2026 · How we verify